December 12-13, 2024 | The Galt House | Louisville, KY | Call For Abstracts Now Open!
Overview
The 6th Annual EGFR Resisters Research Summit will continue the mission of identifying, cultivating, and preparing Young Investigators who work on targeted lung cancer therapies for successful careers dedicated to the advancement of EGFRm NSCLC and improving patient outcomes. Young Investigators will have the opportunity to receive research and career development training by engaging with esteemed faculty, public speaking experts, and peers. The summit will include oral presentations by each finalist, as well as small group discussions and networking opportunities with fellow researchers, expert faculty, and patient advocates.
The EGFR Resisters Research Summit is presented by Creative Educational Concepts LLC (CEC), in collaboration with the EGFR Resisters. For questions, please contact Jessica Hall at hallj@ceconcepts.com.
Call for Abstracts
View the Call for Abstracts PDF or Online | Deadline: Monday, September 30th 11:59pm ET
ELIGIBILITY
- North American-based Junior Faculty and Fellows (MDs, MD/PhDs) involved in research related to EGFR-mutated adenocarcinoma of the lungs. We encourage thoracic oncologists, surgeons, radiation oncologists, pathologists, and related lab-based and translational researchers to submit!
- Junior Faculty (Instructors or Assistant Professors)
- Trainee (Must be enrolled in an ACGME-accredited fellowship program or PhD postdoctoral fellowship)
- PhD Candidates (A limited number of applicants that are conducting lab-based EGFR NSCLC research will be considered)
- Candidates must be based in North America and training must be completed at a North American-based institution.
- All work must be unpublished original research in an area related to EGFR-mutated lung cancer. For junior candidates who do not yet have a scientific abstract to submit, we will also accept a career statement highlighting your goals and trajectory as related to this area, previously published information, journal club presentation, or other like projects representing professional development.
- Abstracts to be presented at future medical meetings are eligible for submission.
ABSTRACT POLICIES AND PROCEDURES
- Only one abstract submission per Young Investigator will be accepted.
- Abstracts must conform to the abstract preparation instructions. Those that do not may be rejected.
- Only original work completed by the Young Investigator will be accepted.
- All accepted abstracts will be published in an electronic program to be provided to all attendees. The publication of electronic handout materials will not preclude publication or presentation elsewhere.
SELECTION PROCESS
- Submission deadline is Monday, September 30th, 2024 at 11:59 PM ET.
- Expert Faculty Judges will review and score all submissions. Number of abstracts to be selected for presentation will depend on quantity and quality of abstracts received.
- Young Investigators selected for participation will present their abstracts in a 15-minute oral presentation at the meeting with 7 minutes of Q&A.
The finalists (authors of accepted abstracts) must attend the meeting in its entirety and will be provided with the following:
• A travel scholarship for lodging, airline, and/or ground transportation, if eligible.*
• All group buffet meals (breakfast, lunch, and dinner) for the duration of the meeting.
• Individualized presentation skills coaching prior to the meeting.
Items that will not be covered include:
• Ground transportation to and from your home airport
• Meals en route
• Baggage fees
Please note: Expenses for accompanying travelers will not be provided. Guests are not permitted to attend any portion of the meeting, including buffet meals.
AWARDS
An awards ceremony will be held at the completion of the meeting, at which time the award winners will be announced.
Grant payments will be made to the affiliated institution of each winning Young Investigator after the live, in-person program date.
*Travel scholarships provided by CE Concepts.
Educational Partners
Supported through an independent educational grant from AstraZeneca.
Follow us on Twitter for the latest updates on the 2024 meeting!